Clinical trials are designed to answer precise questions under highly controlled and monitored conditions.
However once a treatment enters patient’s routine care, it reaches people with different ages, medical histories, treatment journeys, and levels of access. Real life situations are severely different. That is where Real-World Evidence in the Pharmaceutical Industry adds another layer of understanding.
Real-World Data in Pharma comes from sources such as electronic health records, insurance claims, registries, pharmacy records, and digital health tools.
When that same data is analysed to answer a specific clinical or research question, it can generate Real-World Evidence (RWE).
This distinction is important. The significant value from a large dataset comes from whether the information is accurate, relevant, and detailed enough to answer a meaningful question.
Traditional trials help establish whether a treatment is safe and effective in a defined study population. RWE can help pharmaceutical industry and healthcare workers understand how that treatment behaves once it reaches broader, more varied groups of patients.
This can reveal:
This is why Real World Evidence in the Pharmaceutical Industry now supports more than post-market surveillance. It can also assist in clinical development, medical strategy, safety monitoring, and evidence planning.
One common misunderstanding is that real-world evidence is an alternative to randomised clinical trials.
IT DOES NOT.
“It is a false dichotomy to distinguish between real-world data and randomized clinical trials, these are just 2 different dimensions of evidence.” – Dr. Robert M. Califf, former Commissioner of the U.S. FDA and a leading clinical researcher source
Dr. Robert M. Califf, former Commissioner of the U.S. FDA and a leading clinical researcher, has spent much of his career working in clinical trials, health outcomes research, and evidence generation. His point is simple: these two forms of evidence are most useful when they work together.
A clinical trial can show whether a treatment works under defined conditions.
Real-world evidence can help show how that treatment extends and performs when it meets the complexity of everyday care.
Healthcare data is often scattered across Electronic Health Records (EHRs), laboratories, imaging systems, pharmacies, claims databases, and specialist records.
The need is connecting enough of the patient journey to understand what actually happened: What treatment was given, why it was chosen, how the patient responded, and what happened next.
At Mango Sciences, we work with clinically rich healthcare data and advanced analytics to help life sciences organisations and pharma partners understand treatment patterns, patient journeys, and outcomes beyond the controlled environment of a trial.
Because in the end, Real-World Evidence in the Pharmaceutical industry is not about replacing clinical research. It is about completing the picture.
Clinical trials show what a treatment can do. Real-world evidence helps us understand what happens when that treatment meets real patients.
Let’s bridge the gap between clinical trials and real-world care.
Connect with our team at Mango Sciences to explore how real-world data can generate meaningful evidence for life sciences research and decision-making.
https://mangosciences.com/contact-us/
Or write to us at
Email: [email protected]